← Back to deep dive

Review: Advanced Life Support Algorithm

Tables and annotated figures become active recall.


title: "Advanced Life Support Algorithm"

Advanced Life Support Algorithm

πŸ₯

Interactive ALS Runner

Practice the ALS algorithm with real-time drug timing, 2-minute CPR cycles, and training scenarios.

Launch ALS Runner β†’

ALS adult cardiac arrest algorithm (quick reference)

High-Quality CPR

CPR quality determines survival. Before drugs and shocks, get compressions right: 100-120/min, >5cm depth, full recoil, minimal interruptions.

ParameterTargetWhy It Matters
Rate100-120/minLess than 100 or greater than 140 associated with worse survival
Depth>5cm (β…“ chest depth)Generates coronary perfusion pressure
RecoilFull chest recoilAllows venous return
InterruptionsUnder 10 secondsEvery pause drops coronary perfusion to zero
Rescuer changesEvery 2 minutesFatigue degrades quality within 1-2 min
Clinical Pearl

Hands-on-chest time is the single biggest modifiable factor in cardiac arrest survival. Aim for >80% chest compression fraction.

Source: ANZCOR (CPR quality guidance).

Rhythm Classification

ShockableNon-Shockable
VF (Ventricular Fibrillation)Asystole
Pulseless VTPEA (Pulseless Electrical Activity)
Warning

Asystole check: Before calling asystole, confirm leads attached, gain turned up, and check in 2 leads. "Flat line" can be loose leads or fine VF.

Shockable Pathway (VF/pVT)

Shock energy: 200J biphasic (or manufacturer recommendation). Single shock strategy with immediate CPR resumption.

CycleAction
After 1st shockResume CPR immediately Γ— 2 min
After 2nd shockCPR + Adrenaline 1mg IV
After 3rd shockCPR + Amiodarone 300mg IV
After 5th shockConsider Amiodarone 150mg IV
OngoingAdrenaline every 2nd loop (~4 min)
Clinical Pearl

Why adrenaline after 2nd shock? The first two shocks have the best chance of success. Adrenaline is given after the 2nd shock to augment coronary perfusion for subsequent attempts. Don't delay early shocks for drug access.

Non-Shockable Pathway (Asystole/PEA)

ActionTiming
Adrenaline 1mg IVAs soon as feasible (don't wait)
CPR2 minutes
Rhythm checkAfter each 2-min cycle
Repeat adrenalineEvery 2nd loop (~4 min)

In ALS, amiodarone is indicated only for shock-refractory VF/pVT.

Drug Summary

DrugDoseIndicationTiming
Adrenaline1mg IVAll rhythmsNon-shockable: ASAP. Shockable: after 2nd shock. Then q4min
Amiodarone300mg IVShock-refractory VF/pVTAfter 3rd shock
Amiodarone150mg IVRefractory VF/pVTAfter 5th shock (optional)
Lignocaine1 mg/kg IVAlternative to amiodaroneSame timing as amiodarone

Preferred: IV (large peripheral vein, external jugular)

Alternative: IO if IV fails after 2 attempts. Use same doses as IV.

All drugs: Follow with 20-30mL flush + chest compressions to circulate.

Avoid: Lower limb IV (poor circulation during CPR), intracardiac injection (high risk, no benefit).

Source: ANZCOR ALS guidelines; local resuscitation protocols.

Rhythm Transitions

When rhythm changes between shockable and non-shockable, the new pathway's protocol applies from that point. Shock count resets when entering the shockable pathway.

Non-Shockable β†’ Shockable

If a patient starts in PEA/asystole (adrenaline given immediately) and converts to VF/pVT:

Rhythm CheckAction
VF/pVT detectedDeliver 1st shock (in shockable pathway) β†’ CPR 2 min
After 2nd shockAdrenaline 1mg (even if recently given in non-shockable) β†’ CPR 2 min
After 3rd shockAmiodarone 300mg β†’ CPR 2 min
Clinical Pearl

The shock count is specific to the shockable pathway. Even if adrenaline was given during non-shockable rhythm, the shockable pathway drug timing (adrenaline after 2nd shock, amiodarone after 3rd) still applies.

Shockable β†’ Non-Shockable

If VF/pVT degenerates to asystole/PEA:

  • Give adrenaline 1mg immediately (non-shockable protocol = ASAP)
  • No amiodarone β€” it's only for shock-refractory VF/pVT
  • If rhythm converts back to shockable, resume shockable pathway
Warning

Do not give amiodarone if rhythm has converted to non-shockable; it only treats shock-refractory VF/pVT.

The 4 H's and 4 T's

Reversible Causes

4 H's:

  • Hypoxia β†’ Check airway, give Oβ‚‚, consider ETT
  • Hypovolaemia β†’ Rapid IV fluids/blood resuscitation (bolus crystalloids)
  • Hypo/hyperkalaemia β†’ VBG, calcium gluconate for hyperK
  • Hypothermia β†’ Check core temp, warm to 32Β°C before stopping

4 T's:

  • Tension pneumothorax β†’ Chest decompression (needle decompression)
  • Tamponade β†’ Pericardiocentesis, thoracotomy
  • Toxins β†’ Specific antidotes (naloxone, flumazenil, lipid emulsion)
  • Thrombosis (PE/MI) β†’ Consider thrombolysis (PE) or PCI (STEMI)

2nd intercostal space at/just lateral to mid‑clavicular line, or 4th/5th intercostal space anterior axillary line.

Hypoxia β€” Pre-arrest respiratory distress, cyanosis, SpOβ‚‚ trend, airway obstruction

Hypovolaemia β€” Trauma, GI bleed, AAA rupture, ectopic pregnancy. Rapid crystalloid bolus (adult 500-1000 mL; paeds 20 mL/kg). Source: ANZCOR ALS; local resus protocol.

Hyperkalaemia β€” Renal failure, dialysis patient, K-sparing diuretics, ACEi. Look for peaked T waves, wide QRS. Give calcium chloride 10mL of 10% rapid IV.

Hypothermia β€” Drowning, environmental exposure. Continue CPR until core temp >32Β°C ("not dead until warm and dead")

Tension pneumo β€” Trauma, CVC insertion, ventilated patient. Tracheal deviation, absent breath sounds. Needle decompress before CXR.

Tamponade β€” Penetrating chest trauma, post-cardiac surgery, renal failure. Beck's triad (hypotension, muffled hearts, JVP↑). Echo if available, otherwise blind pericardiocentesis.

Toxins β€” Overdose history, toxidromes, QT prolongation. Consider lipid emulsion for local anaesthetic toxicity.

Thrombosis β€” Preceding chest pain (ACS), PE risk factors (DVT, immobility, malignancy). Consider thrombolysis (e.g., alteplase; dose per local PE-in-arrest protocol) if PE suspected β€” continue CPR for 60-90 min after.

Source: ANZCOR ALS guidelines; local hyperkalaemia and hypothermia protocols.

Special Situations

Thrombolysis in Arrest

Clinical Pearl

If PE is suspected as the cause of arrest, consider thrombolysis (e.g., alteplase; dose per local protocol). Continue CPR for 60-90 minutes before considering termination β€” thrombolytics take time to work.

Hypothermic Arrest

  • Withhold adrenaline if core temp below 30Β°C
  • Increase adrenaline interval to 6-10 minutes if temp 30-34Β°C
  • Consider extracorporeal rewarming (ECMO) for refractory arrest

Post-ROSC Care

Once ROSC is achieved:

  1. Airway β€” Secure if not already, confirm ETT position with capnography
  2. Oxygenation β€” Target SpOβ‚‚ 94-98% (avoid hyperoxia)
  3. Ventilation β€” Target normocapnia (PaCOβ‚‚ 35-45 mmHg (~4.7-6.0 kPa))
  4. Circulation β€” MAP >65 mmHg, consider vasopressors/inotropes
  5. 12-lead ECG β€” Look for STEMI β†’ cath lab
  6. Temperature β€” Actively prevent fever (≀ 37.5Β°C) in comatose patients; follow local temperature control protocol
  7. Glucose β€” Avoid hypoglycaemia, target under 10 mmol/L
  8. Cause β€” Identify and treat underlying cause

Temperature control after ROSC: ANZCOR suggests actively preventing fever by targeting ≀ 37.5Β°C in patients who remain comatose after ROSC, and continuing fever prevention for at least 72 hours. Whether hypothermia (32–34Β°C) benefits subgroups remains uncertain.

When to Stop

Consider terminating resuscitation when:

  • Refractory to treatment despite correcting reversible causes
  • No ROSC after 20+ minutes of ALS with non-shockable rhythm
  • Pre-arrest factors suggesting futility (terminal illness, prolonged downtime without CPR)
Warning

Do not stop if: hypothermia (until rewarmed), drug overdose (may need prolonged CPR), or if any reversible cause remains untreated.


Sources